These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22813611)

  • 1. Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy.
    Singh N; Van Craeyveld E; Tjwa M; Ciarka A; Emmerechts J; Droogne W; Gordts SC; Carlier V; Jacobs F; Fieuws S; Vanhaecke J; Van Cleemput J; De Geest B
    J Am Coll Cardiol; 2012 Jul; 60(4):324-31. PubMed ID: 22813611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy.
    Singh N; Heggermont W; Fieuws S; Vanhaecke J; Van Cleemput J; De Geest B
    J Heart Lung Transplant; 2015 Nov; 34(11):1376-84. PubMed ID: 26198441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients.
    Sathya CJ; Sheshgiri R; Prodger J; Tumiati L; Delgado D; Ross HJ; Rao V
    Transpl Int; 2010 Jun; 23(6):641-8. PubMed ID: 20102553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34+CD140b+ cells and circulating CXCL12 correlate with the angiographically assessed severity of cardiac allograft vasculopathy.
    Schober A; Hristov M; Kofler S; Forbrig R; Löhr B; Heussen N; Zhe Z; Akhtar S; Schumann U; Krötz F; Leibig M; König A; Kaczmarek I; Reichart B; Klauss V; Weber C; Sohn HY
    Eur Heart J; 2011 Feb; 32(4):476-84. PubMed ID: 21036775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.
    Huang PH; Huang SS; Chen YH; Lin CP; Chiang KH; Chen JS; Tsai HY; Lin FY; Chen JW; Lin SJ
    J Hypertens; 2010 Aug; 28(8):1655-65. PubMed ID: 20520578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.
    Mehra MR; Uber PA; Potluri S; Ventura HO; Scott RL; Park MH
    Am J Cardiol; 2004 Aug; 94(4):454-8. PubMed ID: 15325928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
    Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
    Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
    Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
    J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allograft vasculopathy in the early phase of orthotopic heart transplantation: angiography, intravascular ultrasound and functional in vivo findings].
    Kerber S; Rahmel A; Karbenn U; Heinemann-Vechtel O; Fechtrup C; Lamp B; Block M; Budde T; Hoffmeier A; Weyand M
    Z Kardiol; 1994 Mar; 83(3):215-24. PubMed ID: 8178545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of immunological markers as mediators of graft vasculopathy development in heart transplantation.
    Mirabet S; Gelpí C; Roldán C; Brossa V; Mendoza CA; Lopez L; Molto E; Alvaro Y; Martinez V; Padró JM; Roig E
    Transplant Proc; 2011; 43(6):2253-6. PubMed ID: 21839249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
    Raichlin E; Edwards BS; Kremers WK; Clavell AL; Rodeheffer RJ; Frantz RP; Pereira NL; Daly RC; McGregor CG; Lerman A; Kushwaha SS
    J Heart Lung Transplant; 2009 Apr; 28(4):320-7. PubMed ID: 19332257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Watanabe K; Fukushima H; Tanaka T; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2005 May; 45(10):1622-30. PubMed ID: 15893178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients.
    Singh N; Jacobs F; Rader DJ; Vanhaecke J; Van Cleemput J; De Geest B
    J Heart Lung Transplant; 2014 May; 33(5):499-506. PubMed ID: 24630408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of metabolic syndrome on development of cardiac allograft vasculopathy in the transplanted heart.
    Sánchez-Gómez JM; Martínez-Dolz L; Sánchez-Lázaro I; Almenar L; Sánchez-Lacuesta E; Muñoz-Giner B; Portolés M; Rivera M; Valera-Román A; González-Juanatey JR; Tejada-Ponce D; Agüero J; Buendía F; Salvador A
    Transplantation; 2012 Jan; 93(1):106-11. PubMed ID: 22134367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis.
    Simper D; Wang S; Deb A; Holmes D; McGregor C; Frantz R; Kushwaha SS; Caplice NM
    Circulation; 2003 Jul; 108(2):143-9. PubMed ID: 12835206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
    J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy.
    Miller WL; Edwards BS; Kremers WK; Kushwaha SS; McGregor CG; Daly RC; Jaffe AS
    J Heart Lung Transplant; 2005 Dec; 24(12):2075-8. PubMed ID: 16364852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
    Loupy A; Coutance G; Bonnet G; Van Keer J; Raynaud M; Aubert O; Bories MC; Racapé M; Yoo D; Duong Van Huyen JP; Bruneval P; Taupin JL; Lefaucheur C; Varnous S; Leprince P; Guillemain R; Empana JP; Levine R; Naesens M; Patel JK; Jouven X; Kobashigawa J
    Circulation; 2020 Jun; 141(24):1954-1967. PubMed ID: 32363949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
    Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
    Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.